GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » PensionAndRetirementBenefit

OSTX (OS Therapies) PensionAndRetirementBenefit : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies PensionAndRetirementBenefit?

OS Therapies's PensionAndRetirementBenefit for the quarter that ended in Dec. 2024 was $0.00 Mil.


OS Therapies PensionAndRetirementBenefit Historical Data

The historical data trend for OS Therapies's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies PensionAndRetirementBenefit Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
PensionAndRetirementBenefit
- - - -

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

OS Therapies PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


OS Therapies Business Description

Traded in Other Exchanges
N/A
Address
115 Pullman Crossing Road, Suite 103, Grasonville, MD, USA, 21638
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.